You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.

DUBLIN, July 29, 2020 /PRNewswire/ -- The "Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN, Antisense), Product & Service, Application (Cell Line Engineering, Genetic Engineering, Diagnostics, Drug Discovery & Development), End-User and Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering. Rising government funding and increase in the number of genomic projects, especially in the area of rare diseases, and a growing application horizon are all expected to drive the growth of the genome editing/genome engineering market.Market growth is largely driven by factors such as the rise in government funding, growth in the number of genomics projects, high prevalence of infectious diseases & cancer, technological advancements, increasing production of genetically modified crops, and growing application areas of genomics. However, the high cost of genomic equipment will restrain the growth of this market.Based on technology, the market is segmented into CRISPR, TALEN, ZFN, antisense, and other technologies. CRISPR accounted for the largest share of the genome editing/genome engineering market in 2019. The large share of this segment can be attributed to the ease of use associated with the CRISPR technology and its ability to multiplex.By end-user, the genome editing/genome engineering market is segmented into pharmaceutical companies, biotechnology companies, and academic & government research institutes. The pharmaceutical companies segment accounted for the largest share of the market. The pharmaceutical companies segment accounted for the largest share of the genome editing/genome engineering market in 2019. This is due to the increasing prevalence of infectious diseases and cancer, which is driving research in the pharma sector for drug development.The Asia Pacific is estimated to grow at the highest CAGR during the forecast period. Factors such as the rapid growth in the pharmaceutical and biopharmaceutical industry, the rising number of genomic projects, and the presence of a genetically diverse population have supported the region's high growth rate. Key Topics Covered: 1 Introduction2 Research Methodology3 Executive Summary4 Premium Insights5 Market Overview5.1 Introduction5.2 Market Dynamics: Drivers, Opportunities, and Challenges5.3 Value Chain Analysis5.4 Impact of Covid-19 Outbreak on the Genome Editing/Genome Engineering Market6 Genome Editing/Genome Engineering Market, by Technology6.1 Introduction6.2 CRISPR6.3 Talen6.4 ZFN6.5 Antisense6.6 Other Technologies7 Genome Editing/Genome Engineering Market, by Application7.1 Introduction7.2 Cell Line Engineering7.3 Genetic Engineering7.4 Diagnostic Applications7.5 Drug Discovery & Development7.6 Other Applications8 Genome Editing/Genome Engineering Market, by Product & Service8.1 Introduction8.2 Reagents & Consumables8.3 Software & Systems8.4 Services9 Genome Editing/Genome Engineering Market, by End-user9.1 Introduction9.2 Pharmaceutical Companies9.3 Biotechnology Companies10 Genome Editing/Genome Engineering Market, by Region11 Competitive Landscape11.1 Introduction11.2 Market Ranking Analysis11.3 Market Evaluation Framework11.4 Competitive Leadership Mapping11.4.1 Visionary Leaders11.4.2 Dynamic Differentiators11.4.3 Innovators11.4.4 Emerging Companies11.5 Competitive Scenario11.5.1 Key Product Launches11.5.2 Key Partnerships & Collaborations11.5.3 Key Acquisitions12 Company ProfilesBusiness Overview, Products and Services Offered, Recent Developments, the Author's View12.1 Thermo Fisher Scientific12.2 Merck12.3 Horizon Discovery12.4 Genscript12.5 Sangamo Therapeutics12.6 Lonza12.7 Editas Medicine12.8 CRISPR Therapeutics12.9 Eurofins Scientific12.10 Precision Biosciences12.11 Oxford Genetics12.12 Intellia Therapeutics12.13 Synthego12.14 Vigene Biosciences12.15 Epigenie12.16 Integrated DNA Technologies12.17 New England Biolabs12.18 Origene Technologies12.19 Transposagen Biopharmaceuticals12.20 Creative Biogene For more information about this report visit https://www.researchandmarkets.com/r/f02b4l About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com

Answer: Global Market Outlook for the Genome Editing/Genome Engineering Market to 2027 - CRISPR Accounted for Largest Market Share in 2019